Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.05725
+0.000585 (1.03%)
At close: Aug 18, 2026
PVCT Market Cap
PVCT has a market cap or net worth of $23.82 million as of August 18, 2026. Its market cap has decreased by -34.51% in one year.
Market Cap
23.82M
Enterprise Value
26.17M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
ChartMarket Cap Chart
Since April 24, 2002, PVCT's market cap has increased from 4.32K to 23.82M, an increase of 550,921.73%. That is a compound annual growth rate of 42.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 23.82M | 1.37% |
| Dec 31, 2025 | 23.49M | -53.46% |
| Dec 31, 2024 | 50.48M | 25.33% |
| Dec 29, 2023 | 40.27M | -11.35% |
| Dec 30, 2022 | 45.43M | 96.93% |
| Dec 31, 2021 | 23.07M | -1.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cell Source | 40.76M |
| Nuo Therapeutics | 37.27M |
| ProText Mobility | 34.29M |
| BetterLife Pharma | 32.91M |
| EOM Pharmaceuticals Holdings | 25.30M |
| Oncotelic Therapeutics | 19.90M |
| ZIVO Bioscience | 17.81M |
| Finch Therapeutics Group | 16.22M |